Objectives In the absence of consensus, the present meta-analysis was performed to
determine an optimal dosing regimen of vancomycin for neonates. Methods A 'meta …

Abstract Background and Objectives Uncertainty exists regarding the optimal dosing
regimen for vancomycin in different patient populations, leading to a plethora of subgroup …

Dosing of vancomycin is often guided by therapeutic drug monitoring and population
pharmacokinetic models in the intensive care unit (ICU). The validity of these models is …

This study aimed to suggest an initial pediatric vancomycin dose regimen through
population pharmacokinetic-pharmacodynamic modeling. A population pharmacokinetic …

OBJECTIVE Vancomycin is often used in the pediatric cardiac surgical population, but few
pharmacokinetic data are available to guide dosing. METHODS A retrospective, population …

Concern for bacterial resistance and treatment failure with vancomycin trough
concentrations< 10 μg/mL have led guidelines to increase goal concentrations. There is a …

Purpose Oxcarbazepine (OXC) is an antiepileptic drug metabolised to active 10-
monohydroxy derivative (MHD) following oral administration. There are no MHD population …

The aim of this study was to determine the pharmacokinetics/pharmacodynamics of
enrofloxacin (ENR) and danofloxacin (DNX) following intravenous (IV) and intramuscular …

This study aimed to explore vancomycin pharmacokinetics and its covariates in critically ill
neonates and to propose an easy applicable dosing nomogram for initial treatment …

The aim of this study was to evaluate the pharmacokinetics and bioavailability of cefquinome
(CFQ) and ceftriaxone (CTX) following intravenous (IV) and intramuscular (IM) …